Natural Products Screening for the Identification of Selective Monoamine Oxidase-B Inhibitors

AIMS: Monoamine oxidase-B inhibitors (MAO-BIs) are used for the initial therapy of Parkinson’s disease. Also, MAO-BIs have shown to be effective neuroprotective agents in several neurodegenerative diseases. However, some concerns exist regarding the long-term use of these compounds. Meanwhile, natur...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarmouh, Najla O., Messeha, Samia S., Elshami, Faisel M., Soliman, Karam F. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898948/
https://www.ncbi.nlm.nih.gov/pubmed/27341283
http://dx.doi.org/10.9734/EJMP/2016/26453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898948/
https://www.ncbi.nlm.nih.gov/pubmed/27341283
http://dx.doi.org/10.9734/EJMP/2016/26453

Ejemplares similares